{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T21:10:02Z","timestamp":1718053802995},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.arcped.2015.07.001","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T05:35:01Z","timestamp":1440826501000},"page":"1092-1097","source":"Crossref","is-referenced-by-count":10,"title":["L\u2019\u00e9rythropo\u00ef\u00e9tine humaine recombinante chez le nouveau-n\u00e9\u00a0: recommandations pour la pratique clinique de la Soci\u00e9t\u00e9 fran\u00e7aise de n\u00e9onatologie"],"prefix":"10.1016","volume":"22","author":[{"given":"E.","family":"Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Beuch\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Truffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Pouvreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Patkai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Baud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Boubred","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Flamant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-H.","family":"Jarreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2015.07.001_bib0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jpeds.2006.05.011","article-title":"The premature infants in need of transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants","volume":"149","author":"Kirpalani","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2015.07.001_bib0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.semperi.2008.10.006","article-title":"Current controversies in the management of the anemia of prematurity","volume":"33","author":"Bishara","year":"2009","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.arcped.2015.07.001_bib0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2807\/esm.10.02.00519-en","article-title":"Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992\u00a0and 2003\u00a0and impact of nucleic acid testing (NAT)","volume":"10","author":"Pillonel","year":"2005","journal-title":"Euro Surveill"},{"key":"10.1016\/j.arcped.2015.07.001_bib0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jpeds.2009.02.026","article-title":"Effects of transfusions in extremely low birth weight infants: a retrospective study","volume":"155","author":"Valieva","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2015.07.001_bib0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jpeds.2010.09.015","article-title":"Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion","volume":"158","author":"Blau","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2015.07.001_bib0030","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1542\/peds.2010-3178","article-title":"Increased odds of necrotizing enterocolitis after transfusion of red blood cells in premature infants","volume":"127","author":"Paul","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2015.07.001_bib0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jpeds.2011.02.040","article-title":"Red blood cell transfusions are independently associated with intra-hospital mortality in very low birth weight preterm infants","volume":"159","author":"dos Santos","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2015.07.001_bib0040","first-page":"CD003248","article-title":"Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes","volume":"8","author":"Rabe","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2015.07.001_bib0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clp.2008.09.013","article-title":"Iron therapy for preterm infants","volume":"36","author":"Rao","year":"2009","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.arcped.2015.07.001_bib0050","first-page":"CD004868","article-title":"Late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"4","author":"Aher","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2015.07.001_bib0055","first-page":"CD004863","article-title":"Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"4","author":"Ohlsson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2015.07.001_bib0060","first-page":"CD004865","article-title":"Early versus late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"10","author":"Aher","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2015.07.001_bib0065","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0022-3476(98)70320-8","article-title":"High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group","volume":"132","author":"Maier","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2015.07.001_bib0070","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-3476(96)70363-3","article-title":"Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution","volume":"128","author":"Ohls","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2015.07.001_bib0075","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/apa.12193","article-title":"How to administrate erythropoietin, intravenous or subcutaneous?","volume":"102","author":"Costa","year":"2013","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.arcped.2015.07.001_bib0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.2007-2591","article-title":"An approach to using recombinant erythropoietin for neuroprotection in very preterm infants","volume":"122","author":"Fauchere","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2015.07.001_bib0085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1542\/peds.2007-2711","article-title":"A phase I\/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety","volume":"122","author":"Juul","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2015.07.001_bib0090","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/PL00008390","article-title":"Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?","volume":"159","author":"Romagnoli","year":"2000","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.arcped.2015.07.001_bib0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaapos.2005.09.005","article-title":"Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity","volume":"10","author":"Brown","year":"2006","journal-title":"J Aapos"},{"key":"10.1016\/j.arcped.2015.07.001_bib0100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaapos.2007.08.009","article-title":"Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model","volume":"12","author":"Suk","year":"2008","journal-title":"J AAPOS"},{"key":"10.1016\/j.arcped.2015.07.001_bib0105","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00431-014-2332-4","article-title":"Erythropoietin and retinopathy of prematurity: a meta-analysis","volume":"173","author":"Xu","year":"2014","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.arcped.2015.07.001_bib0110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.jp.7200244","article-title":"Neurodevelopmental outcome of prematurely born children treated with recombinant human erythropoietin in infancy","volume":"19","author":"Newton","year":"1999","journal-title":"J Perinatol"},{"key":"10.1016\/j.arcped.2015.07.001_bib0115","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1542\/peds.2003-1129-L","article-title":"Neurodevelopmental outcome and growth at 18\u00a0to 22\u00a0months\u2019 corrected age in extremely low birth weight infants treated with early erythropoietin and iron","volume":"114","author":"Ohls","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2015.07.001_bib0120","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.1542\/peds.2005-3186","article-title":"Erythropoietin concentrations and neurodevelopmental outcome in preterm infants","volume":"118","author":"Bierer","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2015.07.001_bib0125","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.1542\/peds.2008-2701","article-title":"Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants","volume":"124","author":"Brown","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2015.07.001_bib0130","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ana.21977","article-title":"Erythropoietin improves neurodevelopmental outcome of extremely preterm infants","volume":"67","author":"Neubauer","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.arcped.2015.07.001_bib0135","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jama.2014.9645","article-title":"Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age","volume":"312","author":"Leuchter","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.arcped.2015.07.001_bib0140","doi-asserted-by":"crossref","first-page":"e1135","DOI":"10.1542\/peds.2009-2268","article-title":"Human recombinant erythropoietin in asphyxia neonatorum: pilot trial","volume":"125","author":"Elmahdy","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2015.07.001_bib0145","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1542\/peds.2008-3553","article-title":"Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy","volume":"124","author":"Zhu","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2015.07.001_bib0150","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1542\/peds.2012-0498","article-title":"Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics","volume":"130","author":"Wu","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2015.07.001_bib0155","series-title":"Efficacy of erythropoietin to improve survival and neurological outcome in hypoxic ischemic encephalopathy (Neurepo). ClinicalTrials.gov","author":"Patkai","year":"2014"},{"key":"10.1016\/j.arcped.2015.07.001_bib0160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jpeds.2013.10.084","article-title":"Feasibility and safety of erythropoietin for neuroprotection after perinatal arterial ischemic stroke","volume":"164","author":"Benders","year":"2014","journal-title":"J Pediatr"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X15002705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X15002705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T20:33:21Z","timestamp":1718051601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X15002705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0929693X15002705"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2015.07.001","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}